Correlation of Residual Diuresis with MIS Score and Nutritional Status in Peritoneal Dialysis Patients: A Croatian Nationwide Study

Open access


Introduction. Residual diuresis (RD) is an important predictor of mortality and cardiovascular (CV) deaths in peritoneal dialysis (PD) patients, and contributes more to overall survival compared to PD clearance. In this study we investigated the correlation between RD and CV outcomes in PD patients.

Methods. A total of 190 PD patients from 13 dialysis centers, a national representation, were included in this analysis. Biomarkers of anemia, nutritional status [malnutrition inflammation score (MIS), subjective global assessment (SGA), serum albumin, anthropometric measurements including body mass index (BMI)], dialysis dose (Kt/V) and laboratory measurements were determined. RD was estimated using the volume of daily urine.

Results. There were 78(41.05 %) females and 112 (58.95 %) males; aged 57.35±14.41 years, on PD for 24.96±24.43 months. Fifty-six patients had diabetes type II (44 as primary kidney disease). The mean RD was 1170±673.6 ml (range 0-3000 mL). Statistically significant correlations between RD and BMI, hip circumference, time on PD, Kt/V, MIS, SGA, erythrocytes (E), Hemoglobin (Hb), PTH, and serum albumin were observed.

Conclusions. We demonstrated a significant correlation between RD and MIS score, SGA, anthropometry and albumin. Every effort should be invested to maintain RD for as long as possible to achieve optimal treatment results and to decrease CV mortality in PD population.

1. Foley RN, Culleton BF, Parfrey PS, et al. Cardiac disease in diabetic end-stage renal disease. Diabetologia 1997; 40: 1307-1312.

2. Maiorca R, Brunori G, Zubani R, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10: 2295-2305.

3. Diaz-Buxo JA, Lowrie EG, Lew NL, et al. Association of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis 1999; 33: 523-534.

4. Rocco M, Soucie JM, Pastan S, et al. Peritoneal dialysis adequacy and risk of death. Kidney Int 2000; 58: 446-457.

5. Rocco MV, Frankenfield DL, Prowant B, et al. Centers for Medicare & Medicaid Services Peritoneal Dialysis Core Indicators Study Group. Risk factors for early mortality in U.S. peritoneal dialysis patients: impact of residual diuresis. Perit Dial Int 2002; 22: 371-379.

6. Szeto CC, Wong TY, Chow KM, et al. Independent effects of renal and peritoneal clearances on the mortality of peritoneal dialysis patients. Perit Dial Int 2004; 24: 58-64.

7. Szeto CC, Wong TY, Leung CB, et al. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 2000; 58: 400-407.

8. Ates K, Nergizoglu G, Keven K, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60: 767-776.

9. Bargman JM, Thorpe KE, Churchill DN, et al. Relative contribution of residual diuresis and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12: 2158-2162.

10. Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307-1320.

11. Termorshuizen F, Korevaar JC, Dekker FW, et al. The relative importance of residual diuresis compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 2003; 41: 1293-1302.

12. Chung SH, Heimburger O, Stenvinkel P, et al. Association between residual diuresis, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant 2003; 18: 590-597.

13. Krediet RT. How to preserve residual diuresis in patients with chronic kidney disease and on dialysis? Nephrol Dial Transplant 2006; 21 Suppl 2: ii42-ii46.

14. Foley RN, Parfrey PS, Harnett JD, et al. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 1996; 7: 728-736.

15. Moon KH, Song IS, Yang WS, et al. Hypoalbuminemia as a risk factor for progressive left ventricular hypertrophy in hemodialysis patients. Am J Nephrol 2000; 20: 396-401.

16. Wang AY, Wang M, Woo J, et al. A novel association between residual diuresis and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002; 6 2: 639-647.

17. Shemin D, Bostom AG, Lambert C, et al. Residual diuresis in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition. Perit Dial Int 2000; 20: 439-444.

18. Wang AY, Sea MM, Ip R, et al. Independent effects of residual diuresis and dialysis adequacy on actual dietary protein, calorie and other nutrients intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001; 12: 2450-2457.

19. CANADA-USA (CANUSA). Peritoneal dialysis study group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198-207.

20. McCusker FX, Teehan BP, Thorpe KE, et al. For the CANADA-USA (CANUSA) Peritoneal Dialysis Study Group. How much peritoneal dialysis is required for maintenance of a good nutritional state? Kidney Int 1996; 50 (Suppl 56): S56-S61.

21. Suda T, Hiroshige K, Ohta T, et al. The contribution of residual diuresis to overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant 2000; 15: 396-401.

22. Stenvinkel P, Carrero JJ, Axelsson J, et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008; 3: 505-521.

23. Silberberg JS, Rahal DP, Patton R, Sniderman AD. Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease. Am J Cardiol 1989; 64: 222-224.

24. García-Lopez E, Carrero JJ, Suliman ME, et al. Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis. Perit Dial Int 2007; 27 (Suppl 2): S205-S209.

25. Noordzij M, Voormolen NM, Boeschoten EW, et al. Disordered mineral metabolism is not a risk factor for loss of residual diuresis in dialysis patients. Nephrol Dial Transplant 2009; 24: 1580-1587.

26. Lopez-Menchero R, Miguel A, Garcia-Ramon R, et al. Importance of residual diuresis in continuous ambulatory peritoneal dialysis: its influence on different parameters of renal replacement treatment. Nephron 1999; 83: 219-225.

27. Dong J, Wang H, Wang M. Low prevalence of hyperphosphatemia independent of residual diuresis in peritoneal dialysis patients. J Ren Nutr 2007; 17: 389-396.

28. Menon MK, Naimark DM, Bargman JM, et al. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual diuresis. Nephrol Dial Transplant 2001; 16: 2207-2213.

29. Zhang L, Zeng X, Fu P, Wu HM. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients. Cochrane Database Syst Rev 2014; 6: CD009120.

30. Cheng LT, Chen W, Tang W, Wang T. Residual diuresis and volume control in peritoneal dialysis patients. Nephron Clin Pract 2006; 104: c47-54.

31. Liao CT, Shiao CC, Huang JW, et al. Predictors of faster decline of residual diuresis in Taiwanese peritoneal dialysis patients. Perit Dial Int 2008; 28: S191-S195.

32. Shin SK, Noh H, Kang SW, et al. Risk factors influencing the decline of residual diuresis in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999; 19: 138-142.

33. Qi H, Xu C, Yan H, Ma J. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials. Perit Dial Int 2011; 31: 179-188.

34. Termorsmhuizen F, Dekker FW, van Manen JG, et al. Relative contribution of residual diuresis and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 2004; 15: 1061-1070.

35. Wang AY. Cardiovascular risk factors in peritoneal dialysis patients revisited. Perit Dial Int 2007; 27 (Suppl 2): S223-S227.

36. Wang AY, Lai KN. The importance of residual diuresis in dialysis patients. Kidney Int 2006; 69: 1726-1732.

37. Wang AY, Woo J, Wang M, et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual diuresis. Nephrol Dial Transplant 2005; 20: 396-403.

38. Basic-Jukic N, Racki S, Kes P, et al. How to prevent protein-energy wasting in patients with chronic kidney disease-position statement of the Croatian Society of Nephrology, Dialysis and Transplantation. Acta Med Croatica 2014; 68: 191-199.

39. Basic-Jukic N, Radic J, Klaric D, et al. Croatian guidelines for screening, prevention and treatment of protein-energy wasting in chronic kidney disease patients. Lijec Vjesn 2015; 137: 1-8.

40. Carrero JJ, Stenvinkel P, Cuppari L, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr 2013; 23: 77-90.

41. Tinroongroj N, Jittikanont S, Lumlertgul D. Relationship between malnutrition-inflammation syndrome and ultrafiltration volume in continuous ambulatory peritoneal dialysis patients. J Med Assoc Thai 2011; 94 (Suppl 4): S94-100.

42. Li ZJ, An X, Mao HP, et al. Association between depression and malnutrition-inflammation complex syndrome in patients with continuous ambulatory peritoneal dialysis. Int Urol Nephrol 2011; 43: 875-882.

43. Van Olden RW, Krediet RT, Struijk DG, et al. Measurement of residual diuresis in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996; 7: 745-750.

44. Nolph KD, Moore HL & Twardowski ZJ, et al. Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis. ASAIO J 1992; 38: M139-M142.

45. Yang Q, Li R, Zhong Z, et al. Is cystatin C a better marker than creatinine for evaluating residual diuresis in patients on continuous ambulatory peritoneal dialysis? Nephrol Dial Transplant 2011; 26: 3358-3365.

46. Mak TW, Cheung CK, Cheung CM, et al. Interference of creatinine measurement in CAPD fluid was dependent on glucose and creatinine concentrations. Nephrol Dial Transplant 1997; 12: 184-186.

Journal Information


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 344 212 14
PDF Downloads 111 82 7